Page last updated: 2024-10-31

neostigmine and Post-Cholecystectomy Syndrome

neostigmine has been researched along with Post-Cholecystectomy Syndrome in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madácsy, L1
Velösy, B1
Lonovics, J1
Csernay, L1
Utsunomiya, N1
Tanaka, M1
Ogawa, Y1
Konomi, H1
Takahata, S1
Nabae, T1
Yokohata, K1
Chijiiwa, K1

Other Studies

2 other studies available for neostigmine and Post-Cholecystectomy Syndrome

ArticleYear
Evaluation of results of the prostigmine-morphine test with quantitative hepatobiliary scintigraphy: a new method for the diagnosis of sphincter of Oddi dyskinesia.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:3

    Topics: Adult; Biliary Tract; Common Bile Duct Diseases; Female; Humans; Liver; Middle Aged; Morphine; Neost

1995
Pain associated with phase III of the duodenal migrating motor complex in patients with postcholecystectomy biliary dyskinesia.
    Gastrointestinal endoscopy, 2000, Volume: 51, Issue:5

    Topics: Adult; Aged; Biliary Dyskinesia; Ceruletide; Duodenum; Humans; Injections, Intramuscular; Manometry;

2000